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Objective: We studied the effects of interleukin 6 (IL-6) and tumor necrosis factor-a (TNF-a) on the
proliferation of porcine theca interna (TI) cells and further elucidated the roles of IL-6 and TNF-a in the
pathogenesis of polycystic ovary syndrome.
Materials and Methods: TI cells were treated with 10 pg/mL, 100 pg/mL, and 1000 pg/mL IL-6 or TNF-a. TI
cell proliferation was then examined by carboxyﬂuorescein diacetate succinimidyl ester labeling and
ﬂow cytometry.
Results: Cell proliferation was not signiﬁcantly different in TI cells cultured in medium alone (control) or
in the presence of IL-6. At 72 hours of treatment, the mean ﬂuorescence intensity was signiﬁcantly lower
in TI cells treated with 100 pg/mL and 1000 pg/mL TNF-a than in the control (p < 0.05).
Conclusion: TNF-a, but not IL-6, was able to promote TI cell proliferation. Our results suggest that TNF-a
might play a role in hyperandrogenism, cortex thickness, and the increased ovary volume observed in
polycystic ovaries.
Copyright © 2016, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).Introduction
Polycystic ovary syndrome (PCOS) is a complex disorder of the
nervouseendocrineemetabolic network. At present, its pathogen-
esis is unclear. Recently, many studies have reported that the
expression of inﬂammatory factors, such as C-reactive protein
(CRP), interleukin IL-6, and tumor necrosis factor-a (TNF-a) are
higher in PCOS patients than in the normal population. Further-
more, the occurrence and development of PCOS have a close rela-
tionship with inﬂammatory factors [1e6].
The serum level of IL-6 in PCOS patients is higher than that in
normal controls [2]. There are polymorphisms in the IL-6 gene
promoter (597G/A, 174G/C) of PCOS patients when compared toter, Shanghai First Maternity
edicine, 550 Hunan Road,
ming@hotmail.com (X. Teng).
bstetrics & Gynecology. Published bnormal controls [7]. The IL-6 receptor consists of two heterodimeric
subunits, IL6R-a (gp80) and IL6R-b (gp130). In gp130, the genotype
frequency of Gly148Arg in PCOS patients is lower than in normal
controls [8]. This study also found an association of IL-6 with the
metabolism imbalance disease PCOS.
Yang et al [9] reported that the serum level of TNF-a in PCOS
patients is higher than that in normal controls. Peral et al [10] re-
ported that themethionine 196 arginine polymorphism in exon 6 of
the TNF receptor 2 gene (TNFRSF1B) is associated with PCOS and
hyperandrogenism. These ﬁndings suggest that inﬂammatory fac-
tors play a role in the pathogenesis of PCOS [10]. IL-6 and TNF-a
levels in follicular ﬂuid of PCOS patients are also higher than those
in control women [11].
Recently, the inﬂammation theory has attracted signiﬁcant
attention. Inﬂammation is correlated with many diseases including
atherosclerosis, diabetes mellitus, and obesity. Patients with these
diseases have high levels of many inﬂammatory factors, indicating
long-term and chronic subclinical inﬂammation (no acute inﬂam-
mation symptoms). PCOS is often accompanied by obesity, diabetesy Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license
Table 1
Mean ﬂuorescence intensity (MFI) of theca interna cells treated with various
concentrations of interleukin-6 (n ¼ 9; 72 hours of treatment).
Group (pg/mL) MFI p
0 66.9 ± 14.8
10 68.6 ± 13.4 > 0.05
100 65.8 ± 6.7 > 0.05
1000 63.7 ± 8.81 > 0.05
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unknown whether inﬂammation is correlated with the pathogen-
esis of PCOS.
PCOS may be an inﬂammatory disease, and the inﬂammation
theory may explain its pathogenesis. Theca interna (TI) cells secret
testosterone, and androstenedione. IL-6 and TNF-a are familiar to
all. Therefore, in this study, we examined the effects IL-6 and TNF-a
on TI cell proliferation to further explore the relationship between
IL-6, TNF-a, and PCOS pathogenesis.
Materials and methods
Reagents and equipment
Porcine recombinant IL-6 and TNF-a were obtained from Pros-
pec (Rehovot, Israel), Dulbecco's modiﬁed Eagle medium (DMEM)/
F12 (1:1) was purchased from Hyclone (Logan, UT, USA) and
collagenase II was purchased from TBD (Tianjin, China). Hyal-
uronidase and trypsin were obtained from Sigma-Aldrich (St Louis,
MO, USA). Fetal bovine serum (FBS) was from Sijiqing (Hangzhou,
China). A carboxyﬂuorescein diacetate succinimidyl ester (CFDA SE)
cell proliferation and tracer detection kit were from Pik-day
Biotechnology Research Institute (Lianyungang, China), and an
aromatizing enzyme immunohistochemistry kit was purchased
from Jingmei Biotech Co., Ltd (Shenzhen, China). Acetic acid (36%)
was obtained from Shanghai Chemical Reagent Company
(Shanghai, China). The ﬂuorescence microscope (TE2000-U) was
purchased from Nikon Eclipse (Tokyo, Japan). The FACSCalibur ﬂow
cytometer was purchased from Becton Dickinson (Franklin Lakes,
NJ, USA).
Isolation and culture of primary porcine TI cells
Fresh porcine ovaries were acquired from an abattoir and placed
in ice-cold two-antibiotic physiological saline (containing
800,000 IU penicillin and 800,000 IU streptomycin per 500 mL).
The ovaries were kept on ice and transported to the laboratory
within 2 hours of slaughter. The ovaries were washed repeatedly
with normal physiological saline. Healthy follicles with a diameter
of 4e6 mmwere carefully cut in half with microdissection scissors
under a dissecting microscope to allow the ﬂuid to ﬂow out.
Granulosa cells (GCs) attached to the surface were scraped off with
a curette. The hat-shaped folliculi interna thecas were separated
with micro-tweezers and washed several times with physiological
saline. The thecas were shredded and then digested with an
enzyme solution (0.25% collagenase II, 0.05% hyaluronidase, and
0.05% trypsin) in a 37C incubator with 5% CO2 for 20e50 minutes.
The samples were then ﬁltered through a 100 mesh stainless steel
ﬁlter. The ﬁltered cell suspension was centrifuged for 5 minutes at
682 g and then washed with normal physiological saline.
The obtained TI cells were resuspended in DMEM/F12 contain-
ing 1% two-antibiotic and 10% FBS. Trypan blue staining showed
>70% viability.
Assessment of TI cell purity
TI cells are often contaminated with ovarian GCs. Aromatizing
enzyme converts testosterone into estradiol and androstenedione
into estrone, which is expressed in GCs but not TI cells. Therefore,
we tested for the presence of aromatizing enzyme to determine the
purity of TI cells by immunohistochemistry.
TI cells were cultured in six-well plates containing coverslips.
The cell suspension was diluted to 1  105 cells/mL by addition of
3 mL DMEM/F12 containing 10% FBS. The cells were incubated at
37C with 5% CO2. The culture mediumwas changed after 48 hours,and the purity of the cells was determined according to the
immunohistochemistry kit instructions. GCs were stained, while TI
cells were unstained. The results showed < 10% GCs.CFDA SE labeling of cells and stimulation with IL-6 and TNF-a
TI cells were labeled according to the instructions of the CFDA SE
detection kit. The labeled TI cells were diluted to 1 105 cells/mL by
addition of 1 mL DMEM/F12 and seeded in 24-well plates. IL-6 or
TNF-a were then added to the cultures at ﬁnal concentrations of
0 pg/mL (control), 10 pg/mL, 100 pg/mL, or 1000 pg/mL in triplicate
wells. The cells were incubated at 37C with 5% CO2. The media
were refreshed after 48 hours, and ﬂow cytometry was performed
after 72 hours.
CFDA SE (formula C29H19NO11; molecular weight 557.47) is a
dye that can penetrate cell membranes, it is catalyzed into CFSE by
the esterase activity of the cells. CFSE binds spontaneously and
irreversibly to acellular protein lysine residues or other available
amine groups, marking the proteins. Full labeling is achieved at
about 24 hours after addition of the ﬂuorescent probe. Because the
ﬂuorescence of cells labeledwith CFDA SE is uniform and stable, the
ﬂuorescence of progeny cells will be halved with every division.
Therefore, ﬂow cytometry can be used to detect these varying de-
grees of ﬂuorescence in CFDA SE-labeled cells to detect up to eight
cell divisions.Flow cytometric detection of TI cell proliferation
After collection by trypsinization, each group of cells was
washed once with PBS and then diluted with PBS to an appropriate
concentration for ﬂow cytometric analysis. Ten thousand cells were
analyzed by the ﬂowcytometer. FlowJo (Tree Star, Inc) softwarewas
used to analyze the mean ﬂuorescence intensity (MFI) of each
group of cells.Statistical analysis
Data were analyzed with SPSS 16.0 (SPSS Inc., Chicago, IL) and
are expressed as the mean ± standard deviation. Comparisons
among multiple groups were analyzed by one-way analysis of
variance. A p value of < 0.05 was considered statistically signiﬁcant.Results
Effects of IL-6 on TI cell proliferation
The MFI of the three experimental groups treated with 10 pg/
mL, 100 pg/mL, or 100 pg/mL IL-6 were compared with the un-
treated control group at 72 hours. The results are shown in Table 1.
Cell proliferation was not signiﬁcantly different in TI cells treated
with or without IL-6.
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The MFI of cells treated with 100 pg/mL or 1000 pg/mL TNF-a at
72 hours was signiﬁcantly lower than that of untreated cells
(53.2 ± 11.59 vs. 66.87 ± 14.8, p ¼ 0.013; 47.55 ± 7.31 vs.
66.87± 14.8, p¼ 0.001), whereas 10 pg/mLTNF-a had no signiﬁcant
effect on the MFI (60.2 ± 9.2 vs 66.87 ± 14.8, p ¼ 0.21; Figures 1e5
and Table 2).Figure 2. Fluorescence of theca interna cells at 72 hours (tumor necrosis factor-a
10 pg/mL).Discussion
The ovary is composed of the cortex and medulla. The outer
peripheral portion of the cortex in the ovary is thick with follicles at
various development stages, the corpus luteum, as well as atresic
and degenerative follicles. The medulla is located in the center of
the ovary, and is mainly composed of loose connective tissue. In
secondary follicles, the theca constantly thickens with the growth
of the follicles, forming the inner and outer membranes. The outer
membrane is mainly composed of dense connective tissue, a small
number of spindle cells, blood vessels, and smooth muscle. The
inner membrane consists of loose connective tissue and abundant
vessels, which contains a large number of theca cells. At this time,
the theca cells have a large volume and nucleus, prominent
nucleoli, and the cytoplasm is enriched with smooth endoplasmic
reticulum, tubular cristae of mitochondria, and lipid droplets with
typical characteristics of steroid synthesis.
The cholesterol fromplasma is converted to pregnenolone in the
mitochondria of follicular GCs and theca cells. Pregnenolone is
converted to androstenedione and testosterone by 17a-hydroxylase
and 17, 20-lyase, in the smooth-surfaced endoplasmic reticulum of
TI cells. Pregnenolone can be converted to progesterone, and then
progesterone is converted into androstenedione and testosterone
by 3b-hydroxysteroid dehydrogenase in TI cells. Therefore, TI cells
produce and secrete androgen.
Typical pathological changes of PCOS include a signiﬁcant
enlargement (2e5 times) and gray appearance of the ovaries with a
smooth surface and thickened cortex (up to a 33% increase) that
contains a large number of cystic follicles with unequal sizes as well
as colorless and transparent cyst ﬂuid. In the cystic follicles,
microscopic examination showed that the GCs which synthesize
estrogen decrease in layers and quantities. Part follicles are atretic,
GCs undergo apoptosis and disappear. Thecal cells in follicles,
which synthesize androgen, proliferate signiﬁcantly.Figure 1. Fluorescence of theca interna cells at 72 hours (control).Ultrastructural observations indicate that GCs have a large amount
of rough endoplasmic reticulum, multiple ribosomes, well-
developed Golgi, and many mitochondria, which remind the
decreased levels of estrogen synthesis. Thecal cells also have a large
amount of smooth endoplasmic reticulum, as well as small lipid
droplets and tubular mitochondria, indicating active androgen
synthesis [12].
In 1975, Carswell et al [13] found a factor that could destroy tumor
cells and cause hemorrhaging and necrosis in tumor tissue in vivo. It
wasnamed tumornecrosis factor byOld [14]. TNF-ahas abroad range
of sources including various immune cells, endothelial cells, ﬁbro-
blasts, epithelial cells, and smooth muscle cells with activated
monocytes/macrophages cells as the main source. TNF-a also has a
wide range of biological activities. It is anti-infective and can cause
fever, destroys or inhibits tumor cells, enhances the phagocytic ca-
pacity of neutrophils [15], strengthens the function of antibody-
dependent cell mediated cytotoxicity, induces acute-phase protein
synthesis in liver cells, inhibits virus replication, and plays an
important role in the regulation of sugar and fat metabolism.Figure 3. Fluorescence of theca interna cells at 72 hours (tumor necrosis factor-a
100 pg/mL).
Figure 5. Effect of tumor necrosis factor (TNF)-a on the proliferation of theca interna
cells at 72 hours. n ¼ 9. * p < 0.05 vs. control. MFI ¼ mean ﬂuorescence intensity;
TNF-a ¼ tumor necrosis factor-a.
Table 2
Mean ﬂuorescence intensity (MFI) of theca interna cells treated with various
concentrations of tumor necrosis factor-a (n ¼ 9; 72 hours of treatment).
Group (pg/mL) MFI p
0 66.9 ± 14.8
10 60.2 ± 9.2 > 0.05
100 53.2 ± 11.6 < 0.05
1000 47.6 ± 7.3 < 0.05
Figure 4. Fluorescence of theca interna cells at 72 hours (tumor necrosis factor-a
1000 pg/mL).
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normal cells, as well as a variety of tumor cells. The mechanism of
signal transduction followed by TNF-a binding to its corresponding
receptor is not yet clear. Present studies have shown that TNF-a has
three different signaling pathways that generate distinct effects,
including apoptosis, nuclear factor-kB, and c-Jun N-terminal kinase
signaling pathways [16].
It has been reported that TNF-a has a role in the promotion of
hyperandrogenism [17]. Our study revealed that high doses of TNF-
a stimulated the proliferation of TI cells, indicating that TNF-a has a
role in the thickness of the cortex, the increased ovary volume, andeven the hyperplasia of follicle numbers, the tunica albuginea, and
ovarian medulla observed in PCOS ovaries. The mechanism of TNF-
a stimulation of cell proliferation is related to activation of JNK and
other signal transduction pathways [18]. TNF-a can also induce
insulin resistance [2], followed by the occurrence of PCOS.
The human IL-6 gene is located in the short arm of chromosome
7. It is about 5 kb including ﬁve exons and four introns. Mature IL-6
contains 184 amino acid residues with a molecular weight was 26
kD. T cells, B cells, monocytes, ﬁbrocytes and fat cells produce IL-6.
IL-6 accelerates B cell proliferation, differentiation, and secretion of
antibodies. IL-6 has an anticancer effect, IL-6 promotes the anti-
tumor activity of natural killer cells and cytotoxic T lymphocytes
directly or indirectly. IL-6 also promotes acute phase protein levels
in the liver and inﬂammatory reactions, and contributes to the
growth of hemocytes.
In our study, we showed that IL-6 did not directly promote the
proliferation of TI cells. Therefore, it is unclear how IL-6 participates
in the pathogenesis of PCOS. It is well known that the activity of
androgen is inﬂuenced by several factors such as androgen receptor
(AR). It has been reported that IL-6 upregulates AR expression in
prostate cancer [19]. Similarly, IL-6 might also enhance androgen
activity by upregulation of AR expression in the ovary, leading to
PCOS. In addition, IL-6 might cause insulin resistance ﬁrst, followed
by PCOS [2].
Further studies are needed to demonstrate a connection be-
tween inﬂammatory factors and PCOS pathogenesis. By verifying
the involvement of inﬂammatory factors in the pathogenesis of
PCOS, newmethods may be developed for PCOS treatment, such as
blocking therapeutic targets including inﬂammatory factors and
signaling pathways.Conﬂicts of interest
The authors have no conﬂicts of interest relevant to this article.Acknowledgments
This work was supported by a Shanghai First Maternity and
Infant Hospital Seed Grant (201005; Shanghai, China) and a Tongji
University Outstanding Youth Training Program Grant (2010KJ019;
Shanghai, China).References
[1] Pawelczak M, Rosenthal J, Milla S, Liu YH, Shah B. Evaluation of the pro-
inﬂammatory cytokine tumor necrosis factor-a in adolescents with polycy-
stic ovary syndrome. J Pediatr Adolesc Gynecol 2014;27:356e9.
[2] Tarkun I, Cetinarslan B, Türemen E, Cantürk Z, Biyikli M. Association between
circulating tumor necrosis factor-alpha, interleukin-6, and insulin resistance
in normal-weight women with polycystic ovary syndrome. Metab Syndr Relat
Disord 2006;4:122e8.
[3] Thathapudi S, Kodati V, Erukkambattu J, Katragadda A, Addepally U, Hasan Q.
Tumor necrosis factor-alpha and polycystic ovarian syndrome: a clinical,
biochemical, and molecular genetic study. Genet Test Mol Biomarkers
2014;18:605e9.
[4] Xu X, Du C, Zheng Q, Peng L, Sun Y. Effect of metformin on serum interleukin-6
levels in polycystic ovary syndrome: a systematic review. BMC Womens
Health 2014;14:93.
[5] Pedroso DC, Miranda-Furtado CL, Kogure GS, Meola J, Okuka M, Silva C, et al.
Inﬂammatory biomarkers and telomere length in women with polycystic
ovary syndrome. Fertil Steril 2015;103:542e7.
[6] Sahin FK, Sahin SB, Balik G, Ural UM, Tekin YB, Cure MC, et al. Does low
pentraxin-3 levels associate with polycystic ovary syndrome and obesity? Int J
Clin Exp Med 2014;7:3512e9.
[7] Escobar-Morreale HF, Luque-Ramírez M, San Millan JL. The molecular-genetic
basis of functional hyperandrogenism and the polycystic ovary syndrome.
Endocr Rev 2005;26:251e82.
[8] Escobar-Morreale HF, Calvo RM, Villuendas G, Sancho J, San Millan JL.
Association of polymorphisms in the interleukin 6 receptor complex
with obesity and hyperandrogenism. Obes Res 2003;11:987e96.
L. Hong et al. / Taiwanese Journal of Obstetrics & Gynecology 55 (2016) 183e187 187[9] Yang XF, Ren FR, Guo SP. Study on the relationship between serum adipo-
nectin and insulin resistance in women with polycystic ovary syndrome.
Zhonghua Fu Chan Ke Za Zhi 2006;41:261e3.
[10] Peral B, San Millan JL, Castello R, Moghetti P, Escobar-Morreale HF. Comment:
the methionine 196 arginine polymorphism in exon 6 of the TNF receptor
2 gene (TNFRSF1B) is associated with the polycystic ovary syndrome
and hyperandrogenism. J Clin Endocrinol Metab 2002;87:3977e83.
[11] Amato G, Conte M, Mazziotti G, Lalli E, Vitolo G, Tucker AT, et al. Serum and
follicular ﬂuid cytokines in polycystic ovary syndrome during stimulated cy-
cles. Obstet Gynecol 2003;101:1177e82.
[12] Liu SO. Diagnosis and treatment of obstetrics and gynecology syndromes.
Beijing: People's Military Medical Press; 2005. p. 68e9.
[13] Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B. An endotoxin-
induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci U S A
1975;72:3666e70.[14] Old LJ. Tumor necrosis factor (TNF). Science 1985;230:630e2.
[15] Shalaby MR, Aggarwal BB, Rinderknecht E, Svedersky LP, Finkle BS,
Palladino Jr MA. Activation of human polymorphonuclear neutrophil func-
tions by interferon-gamma and tumor necrosis factors. J Immunol 1985;135:
2069e73.
[16] Croft M. The role of TNF superfamily members in T-cell function and diseases.
Nat Rev Immunol 2009;9:271e85.
[17] Escobar-Morreale HF, Calvo RM, Sancho J, San Millan JL. TNF-a and hyper-
androgenism: a clinical, biochemical, and molecular genetic study. J Clin
Endocrinol Metab 2001;86:3761e7.
[18] Korobowicz A. Biology of tumor necrosis factor type alpha (TNF-alpha). Pol
Merkur Lekarski 2006;21:358e61 [In Polish].
[19] Lin DL, Whitney MC, Yao Z, Keller ET. Interleukin-6 induces androgen
responsiveness in prostate cancer cells through up-regulation of androgen
receptor expression. Clin Cancer Res 2001;7:1773e81.
